Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain‐like lesion during the COVID‐19 pandemic
- 25 May 2021
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (9) , E566-E568
Abstract
Chilblain-like lesions (CLL) have been extensively reported during Coronavirus Disease-19 (COVID-19) pandemic in March-April 2020.1 While the link between these lesions and Severe Acute Respiratory Coronavirus 2 (SARS-Cov-2) is still unclear2, emerging evidences of “long COVID”, with extra cutaneous COVID-19 symptoms persisting over 60 days, are reported.3 The aim of this study was to assess the evolution of the CLL overtime. We performed a retrospective study to evaluate the frequency and the characteristics of CLL relapses and the persistence of other cutaneous symptoms. In January 2021, a survey was sent to 132 patients who were addressed to the dermatology department of Saint-Louis hospital, Paris between March 1st and April 30th 2020 for CLL lesions. Ninety-five answers were obtained.Keywords
This publication has 9 references indexed in Scilit:
- Long COVID in the skin: a registry analysis of COVID-19 dermatological durationThe Lancet Infectious Diseases, 2021
- Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 PandemicDermatopathology, 2020
- A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?Medical Hypotheses, 2020
- Evaluation of Chilblains as a Manifestation of the COVID-19 PandemicJAMA Dermatology, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- Vascular skin symptoms in COVID‐19: a French observational studyJournal of the European Academy of Dermatology and Venereology, 2020
- Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing*British Journal of Dermatology, 2020
- Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patientsJournal of the European Academy of Dermatology and Venereology, 2020
- Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from FranceJournal of the American Academy of Dermatology, 2020